Article Information
History
- May 16, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Tiffany Thomas1,
- Davide Stefanoni2,
- Julie A. Reisz2,
- Travis Nemkov2,
- Lorenzo Bertolone2,
- Richard O Francis1,
- Krystalyn E. Hudson1,
- James C. Zimring3,
- Kirk C. Hansen2,
- Eldad A. Hod1,
- Steven L. Spitalnik1,*,† and
- Angelo D’Alessandro2,*,†
- 1Department of Pathology & Cell Biology, Columbia University, New York, NY, USA
- 2Department of Biochemistry and Molecular Genetics, University of Colorado Denver – Anschutz Medical Campus, Aurora, CO, USA
- 3Department of Pathology, University of Virginia, Charlottesville, VA, USA
- ↵†Corresponding authors: Angelo D’Alessandro, PhD Department of Biochemistry and Molecular Genetics University of Colorado Anschutz Medical Campus 12801 East 17th Ave., Aurora, CO 80045 Phone # 303-724-0096 E-mail: angelo.dalessandro{at}ucdenver.edu Steven L. Spitalnik, MD Department of Pathology & Cell Biology Columbia University 630 West 168th Street New York, NY 10032 Phone # 212-305-2204 E-mail: ss2479{at}cumc.columbia.edu
↵* Equally contributing last/senior authors
Posted May 16, 2020.
COVID-19 infection results in alterations of the kynurenine pathway and fatty acid metabolism that correlate with IL-6 levels and renal status
